Christopher Ly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christopher Ly has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Fatima Zahra Jelloul
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
37 shared publications - Hussein A. Abbas
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
37 shared publications - Patrick K. Reville
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA
37 shared publications - Naval Daver
University of Texas, MD Anderson Cancer Center, Houston, Texas, United States
36 shared publications - Bofei Wang
The University of Texas MD Anderson Cancer Center; Houston, United States
35 shared publications - Jessica L. Root
Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
35 shared publications
Latest Publications
- Open Access
Arborist: Prioritizing Bulk DNA Inferred Tumor Phylogenies via Low-pass Single-cell DNA Sequencing Data
Cancer arises from an evolutionary process that can be reconstructed from DNA sequencing and modeled by tumor phylogenies. High coverage bulk DNA sequencing (bulk DNA-seq) is widely available, but tumor phylogeny inference requires deconvolution, often resulting in non-uniqueness in the solution space. Single-cell DNA sequencing (scDNA-seq) holds potential to yield higher resolution tumor phylogenies, but the sparsity of emerging low-pass sequencing technologies poses challenges for the study of single-nucleotide variants. Increasing availability of data sequenced with both modalities provides an opportunity to capitalize on the advantages of these technologies. While inference methods exist for bulk DNA-seq and for low-pass scDNA-seq, no joint inference methods currently exist. As a first step, we propose a method named ARBORIST that prioritizes tumor phylogenies inferred via bulk DNA-seq using low-pass scDNA-seq data. ARBORIST takes as input a candidate set of trees with corresponding SNV clustering, along with variant and total read count data from scDNA-seq and uses variational inference to approximate a lower bound on the marginal likelihood of each tree in the candidate set. On simulated data, matching characteristics of current scDNA-seq data, ARBORIST outperforms both bulk and low-pass single-cell reconstruction methods. On a biological dataset, ARBORIST conclusively resolves the evolutionary relationship between different SNV clusters on a malignant peripheral nerve sheath tumor, which is supported by orthogonal validation via a proxy for copy number. ARBORIST provides a principled framework for integrating bulk DNA-seq and low-pass scDNA-seq data, improving confidence in tumor phylogeny reconstruction. Availability: https://github.com/VanLoo-lab/Arborist
Open AccessArborist: Prioritizing Bulk DNA Inferred Tumor Phylogenies via Low-pass Single-cell DNA Sequencing Data
Cancer arises from an evolutionary process that can be reconstructed from DNA sequencing and modeled by tumor phylogenies. High coverage bulk DNA sequencing (bulk DNA-seq) is widely available, but tumor phylogeny inference requires deconvolution, often resulting in non-uniqueness in the solution space. Single-cell DNA sequencing (scDNA-seq) holds potential to yield higher resolution tumor phylogenies, but the sparsity of emerging low-pass sequencing technologies poses challenges for the study of single-nucleotide variants. Increasing availability of data sequenced with both modalities provides an opportunity to capitalize on the advantages of these technologies. While inference methods exist for bulk DNA-seq and for low-pass scDNA-seq, no joint inference methods currently exist. As a first step, we propose a method named ARBORIST that prioritizes tumor phylogenies inferred via bulk DNA-seq using low-pass scDNA-seq data. ARBORIST takes as input a candidate set of trees with corresponding SNV clustering, along with variant and total read count data from scDNA-seq and uses variational inference to approximate a lower bound on the marginal likelihood of each tree in the candidate set. On simulated data, matching characteristics of current scDNA-seq data, ARBORIST outperforms both bulk and low-pass single-cell reconstruction methods. On a biological dataset, ARBORIST conclusively resolves the evolutionary relationship between different SNV clusters on a malignant peripheral nerve sheath tumor, which is supported by orthogonal validation via a proxy for copy number. ARBORIST provides a principled framework for integrating bulk DNA-seq and low-pass scDNA-seq data, improving confidence in tumor phylogeny reconstruction. Availability: https://github.com/VanLoo-lab/Arborist
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Tables from Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Supplementary Tables from Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables from Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Supplementary Tables from Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Tables from Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Supplementary Tables from Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables from Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Supplementary Tables from Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
- Open Access
Multimodal Spatial Proteomic Profiling in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) resides in an immune rich microenvironment, yet, immune-based therapies have faltered in eliciting durable responses. Bridging this paradox requires a comprehensive understanding of leukemic interactions within the bone marrow microenvironment. We optimized a high-throughput tissue-microarray based pipeline for high-plex spatial immunofluorescence and mass cytometry imaging on a single slide, capturing immune, tumor, and structural components. Using unbiased clustering on the spatial K function, we unveiled the presence of tertiary lymphoid-like aggregates in bone marrow which we validated using spatial transcriptomics and an independent proteomics approach. We then found validated TLS signatures predictive of outcomes in AML using an integrated public 480 patient transcriptomic dataset. By harnessing high-plex spatial proteomics, we open the possibility of discovering of novel structures and interactions that underpin leukemic immune response. Further, our study’s methodologies and resources can be adapted for other bone marrow diseases where decalcification and autofluorescence present challenges.
Open AccessMultimodal Spatial Proteomic Profiling in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) resides in an immune rich microenvironment, yet, immune-based therapies have faltered in eliciting durable responses. Bridging this paradox requires a comprehensive understanding of leukemic interactions within the bone marrow microenvironment. We optimized a high-throughput tissue-microarray based pipeline for high-plex spatial immunofluorescence and mass cytometry imaging on a single slide, capturing immune, tumor, and structural components. Using unbiased clustering on the spatial K function, we unveiled the presence of tertiary lymphoid-like aggregates in bone marrow which we validated using spatial transcriptomics and an independent proteomics approach. We then found validated TLS signatures predictive of outcomes in AML using an integrated public 480 patient transcriptomic dataset. By harnessing high-plex spatial proteomics, we open the possibility of discovering of novel structures and interactions that underpin leukemic immune response. Further, our study’s methodologies and resources can be adapted for other bone marrow diseases where decalcification and autofluorescence present challenges.
- Open Access
- 6 March 2024
- Published by American Association for Cancer Research (AACR)
FIGURE 3 from Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
Exploratory analysis of CR and NR patients at baseline. CRs have significantly higher CD4 effector cytokine expression than NRs in the BM. No significant difference in functional group expression from CD8 cells in either PB and BM between CR and NR.
- 6 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 3 from Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
Exploratory analysis of CR and NR patients at baseline. CRs have significantly higher CD4 effector cytokine expression than NRs in the BM. No significant difference in functional group expression from CD8 cells in either PB and BM between CR and NR.
- Open Access
- 6 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
Baseline T cell individual cytokine activity in PB and BM.
- 6 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
Baseline T cell individual cytokine activity in PB and BM.
- Open Access
- 6 March 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
UMAP visualization depicting batch-corrected Seurat defined clusters.
- 6 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy
UMAP visualization depicting batch-corrected Seurat defined clusters.